SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $24,000 | -25.0% | 100,350 | 0.0% | 0.00% | – |
Q1 2018 | $32,000 | -37.3% | 100,350 | 0.0% | 0.00% | – |
Q4 2017 | $51,000 | -45.7% | 100,350 | 0.0% | 0.00% | – |
Q3 2017 | $94,000 | +64.9% | 100,350 | 0.0% | 0.00% | – |
Q2 2017 | $57,000 | -9.5% | 100,350 | 0.0% | 0.00% | – |
Q1 2017 | $63,000 | -18.2% | 100,350 | 0.0% | 0.00% | – |
Q4 2016 | $77,000 | -55.5% | 100,350 | 0.0% | 0.00% | – |
Q3 2016 | $173,000 | -4.4% | 100,350 | 0.0% | 0.00% | – |
Q2 2016 | $181,000 | -23.6% | 100,350 | 0.0% | 0.00% | – |
Q1 2016 | $237,000 | +3.0% | 100,350 | 0.0% | 0.00% | – |
Q4 2015 | $230,000 | +0.9% | 100,350 | 0.0% | 0.00% | – |
Q3 2015 | $228,000 | -20.3% | 100,350 | 0.0% | 0.00% | – |
Q2 2015 | $286,000 | +64.4% | 100,350 | 0.0% | 0.00% | – |
Q1 2015 | $174,000 | 0.0% | 100,350 | 0.0% | 0.00% | – |
Q4 2014 | $174,000 | -2.8% | 100,350 | 0.0% | 0.00% | – |
Q3 2014 | $179,000 | +3.5% | 100,350 | 0.0% | 0.00% | – |
Q2 2014 | $173,000 | -24.8% | 100,350 | 0.0% | 0.00% | – |
Q1 2014 | $230,000 | +46.5% | 100,350 | 0.0% | 0.00% | – |
Q4 2013 | $157,000 | -7.1% | 100,350 | 0.0% | 0.00% | – |
Q3 2013 | $169,000 | -2.3% | 100,350 | 0.0% | 0.00% | – |
Q2 2013 | $173,000 | – | 100,350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |